{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:49:00Z","timestamp":1772232540997,"version":"3.50.1"},"reference-count":53,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>In 2020, a global pandemic was declared following the spread of SARS-CoV-2, the pathogen responsible for COVID-19. The risk of infection is high due to the ease of transmission, which can occur orally, through droplets, or via contact with contaminated surfaces and objects. It has also been demonstrated that the ocular surface can constitute a transmission route, especially in hospital settings, where health care workers can become a dangerous source of infection. In order to increase prevention and reduce the spread of the virus on the ocular surface, the antiviral activity of already-marketed eye drops against SARS-CoV-2 was evaluated. Iodim, Ozodrop, Septavis, and Dropsept were tested against SARS-CoV-2 in plaque-assay experiments at different stimulation times. Furthermore, the expression levels of early and late genes were evaluated through molecular assays. Results indicated that three of the four ophthalmic solutions showed a considerable dose-dependent inhibition of viral replication, highlighting their use as potential antiviral drugs against SARS-CoV-2 and preventing other ocular infections.<\/jats:p>","DOI":"10.3390\/microorganisms9081550","type":"journal-article","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:07:40Z","timestamp":1626998860000},"page":"1550","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibitory Effect of Ophthalmic Solutions against SARS-CoV-2: A Preventive Action to Block the Viral Transmission?"],"prefix":"10.3390","volume":"9","author":[{"given":"Francesco","family":"Petrillo","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Chianese","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-0064","authenticated-orcid":false,"given":"Maddalena","family":"De Bernardo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-8700","authenticated-orcid":false,"given":"Carla","family":"Zannella","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0174-0209","authenticated-orcid":false,"given":"Marilena","family":"Galdiero","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-6729","authenticated-orcid":false,"given":"Michele","family":"Reibaldi","sequence":"additional","affiliation":[{"name":"Department of Surgical Science, Eye Clinic, University of Turin, 10124 Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresio","family":"Avitabile","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Catania, 95123 Catania, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-6855","authenticated-orcid":false,"given":"Giovanni","family":"Boccia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1576-6290","authenticated-orcid":false,"given":"Massimiliano","family":"Galdiero","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-6556","authenticated-orcid":false,"given":"Nicola","family":"Rosa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3321-4331","authenticated-orcid":false,"given":"Gianluigi","family":"Franci","sequence":"additional","affiliation":[{"name":"Department of Medicine, Surgery and Dentistry \u201cScuola Medica Salernitana\u201d, University of Salerno, 84081 Baronissi, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/jopr.13209","article-title":"Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse","volume":"29","author":"Bidra","year":"2020","journal-title":"J. Prosthodont."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjophthalmol-2020-315994","article-title":"Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear","volume":"104","author":"Li","year":"2020","journal-title":"Br. J. Ophthalmol."},{"key":"ref_3","first-page":"8226","article-title":"Association between the spread of COVID-19 and weather-climatic parameters","volume":"24","author":"Carta","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: Transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"192S","DOI":"10.1177\/0145561320957237","article-title":"Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)","volume":"100","author":"Pelletier","year":"2021","journal-title":"Ear Nose Throat J."},{"key":"ref_6","first-page":"91","article-title":"Organization of preventive health care for children in the USSR","volume":"79","author":"Dimitriewna","year":"1988","journal-title":"Arztl Jugendkd"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","article-title":"Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis","volume":"395","author":"Chu","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-020-04663-2","article-title":"Reply to ocular manifestation, eye protection, and COVID-19","volume":"258","author":"Lai","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fped.2020.00521","article-title":"Effect of Population Lockdown on Pediatric Emergency Room Demands in the Era of COVID-19","volume":"8","author":"Valitutti","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s12630-020-01785-3","article-title":"Personal protective equipment during the COVID-19 pandemic (Letter #2)","volume":"67","author":"Hung","year":"2020","journal-title":"Can. J. Anaesth"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0000000000000339","article-title":"COVID-19 and the Eye: A Comprehensive Review of the Literature","volume":"61","author":"Feng","year":"2021","journal-title":"Int. Ophthalmol. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Petrillo, F., Pignataro, D., Lavano, M.A., Santella, B., Folliero, V., Zannella, C., Astarita, C., Gagliano, C., Franci, G., and Avitabile, T. (2020). Current Evidence on the Ocular Surface Microbiota and Related Diseases. Microorganisms, 8.","DOI":"10.3390\/microorganisms8071033"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/opo.12708","article-title":"COVID-19 and the eye","volume":"40","author":"Lawrenson","year":"2020","journal-title":"Ophthalmic Physiol. Opt."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00417-020-04662-3","article-title":"Ocular manifestation, eye protection, and COVID-19","volume":"258","author":"Mungmungpuntipantip","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/j.jinf.2020.05.054","article-title":"COVID-19 and the Eye","volume":"81","author":"Zhong","year":"2020","journal-title":"J. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","article-title":"Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals","volume":"28","author":"Seah","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/cxo.13088","article-title":"The ocular surface, coronaviruses and COVID-19","volume":"103","author":"Willcox","year":"2020","journal-title":"Clin. Exp. Optom."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2174\/092986609788681742","article-title":"Inhibition of viral-induced membrane fusion by peptides","volume":"16","author":"Vitiello","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/09273948.2020.1772313","article-title":"COVID-19 and the Ocular Surface: A Review of Transmission and Manifestations","volume":"28","author":"Ho","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"612319","DOI":"10.3389\/fphys.2021.612319","article-title":"SARS-COV-2 and Ocular Surface: From Physiology to Pathology, a Route to Understand Transmission and Disease","volume":"12","author":"Camara","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4103\/ijo.IJO_1589_20","article-title":"Potential ocular and systemic COVID-19 prophylaxis approaches for healthcare professionals","volume":"68","author":"Shetty","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1007\/s12325-020-01442-7","article-title":"Novel Insights into the Transmission of SARS-CoV-2 Through the Ocular Surface and its Detection in Tears and Conjunctival Secretions: A Review","volume":"37","author":"Konstas","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jdsr.2021.03.001","article-title":"Can povidone iodine gargle\/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update","volume":"57","author":"Chopra","year":"2021","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/fmb-2020-0286","article-title":"Review of the use of nasal and oral antiseptics during a global pandemic","volume":"16","author":"Stathis","year":"2021","journal-title":"Future Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/alr.22735","article-title":"Prophylactic and therapeutic topical povidone-iodine in coronavirus disease 2019 (COVID-19): What is the evidence?","volume":"10","author":"Yan","year":"2020","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jamaoto.2020.3053","article-title":"In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2","volume":"146","author":"Frank","year":"2020","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/alr.22577","article-title":"Endonasal instrumentation and aerosolization risk in the era of COVID-19: Simulation, literature review, and proposed mitigation strategies","volume":"10","author":"Workman","year":"2020","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"104724","DOI":"10.1016\/j.oraloncology.2020.104724","article-title":"Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as \u201cPersonal Protective Equipment\u201d for frontline providers exposed in high-risk head and neck and skull base oncology care","volume":"105","author":"Mady","year":"2020","journal-title":"Oral Oncol."},{"key":"ref_29","first-page":"2137","article-title":"Self-assembled or mixed peptide amphiphile micelles from Herpes simplex virus glycoproteins as potential immunomodulatory treatment","volume":"9","author":"Accardo","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/jopr.13220","article-title":"Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses","volume":"29","author":"Bidra","year":"2020","journal-title":"J. Prosthodont."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0194599820919751","article-title":"COVID-19 Pandemic: What Every Otolaryngologist-Head and Neck Surgeon Needs to Know for Safe Airway Management","volume":"162","author":"Balakrishnan","year":"2020","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000089211","article-title":"Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents","volume":"212","author":"Kariwa","year":"2006","journal-title":"Dermatology"},{"key":"ref_33","first-page":"4059","article-title":"Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19","volume":"24","author":"Valdenassi","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"569967","DOI":"10.3389\/fbioe.2020.569967","article-title":"Combating Actions of Green 2D-Materials on Gram Positive and Negative Bacteria and Enveloped Viruses","volume":"8","author":"Singh","year":"2020","journal-title":"Front. Bioeng Biotechnol."},{"key":"ref_35","first-page":"2752","article-title":"SARS-CoV-2 vaccine development: Where are we?","volume":"25","author":"Galdiero","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.9.8.4","article-title":"Antimycotic Activity of Ozonized Oil in Liposome Eye Drops against Candida spp.","volume":"9","author":"Celenza","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/myc.12306","article-title":"Filamentous fungal infections of the cornea: A global overview of epidemiology and drug sensitivity","volume":"58","author":"Kredics","year":"2015","journal-title":"Mycoses"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajo.2016.05.021","article-title":"Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study","volume":"168","author":"Ong","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_39","first-page":"14","article-title":"HSV membrane glycoproteins, their function in viral entry and their use in vaccine studies","volume":"Volume 43","author":"Stelitano","year":"2019","journal-title":"Amino Acids, Peptides and Proteins: Volume 43"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000496828","article-title":"Epstein-Barr Virus Seroprevalence and Primary Infection at the University Hospital Luigi Vanvitelli of Naples from 2007 to 2017","volume":"62","author":"Franci","year":"2019","journal-title":"Intervirology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000488846","article-title":"Use of Ozone-Based Eye Drops: A Series of Cases in Veterinary and Human Spontaneous Ocular Pathologies","volume":"9","author":"Spadea","year":"2018","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0976-9668.82319","article-title":"Ozone therapy: A clinical review","volume":"2","author":"Elvis","year":"2011","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2672.2001.01235.x","article-title":"Antibacterial activity of ozonized sunflower oil (Oleozon)","volume":"90","author":"Sechi","year":"2001","journal-title":"J. Appl. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Santella, B., Folliero, V., Pirofalo, G.M., Serretiello, E., Zannella, C., Moccia, G., Santoro, E., Sanna, G., Motta, O., and De Caro, F. (2020). Sepsis-A Retrospective Cohort Study of Bloodstream Infections. Antibiotics, 9.","DOI":"10.3390\/antibiotics9120851"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1111\/aos.14243","article-title":"In vitro antimicrobial activity of a new ophthalmic solution containing povidone-iodine 0.6% (IODIM(R))","volume":"98","author":"Pinna","year":"2020","journal-title":"Acta Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ugazio, E., Tullio, V., Binello, A., Tagliapietra, S., and Dosio, F. (2020). Ozonated Oils as Antimicrobial Systems in Topical Applications. Their Characterization, Current Applications, and Advances in Improved Delivery Techniques. Molecules, 25.","DOI":"10.3390\/molecules25020334"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.mehy.2006.07.039","article-title":"The in vitro effective antiviral action of povidone-iodine (PVP-I) may also have therapeutic potential by its intravenous administration diluted with Ringer\u2019s solution","volume":"68","author":"Sabracos","year":"2007","journal-title":"Med. Hypotheses"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1743-422X-6-124","article-title":"Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: Its effects on hemagglutination and sialidase activities","volume":"6","author":"Sriwilaijaroen","year":"2009","journal-title":"Virol. J."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Singh, S., Sawant, O.B., Mian, S.I., and Kumar, A. (2021). Povidone-Iodine Attenuates Viral Replication in Ocular Cells: Implications for Ocular Transmission of RNA Viruses. Biomolecules, 11.","DOI":"10.3390\/biom11050753"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Caruso, C., Eletto, D., Rinaldi, M., Pacente, L., Troisi, S., Semeraro, F., dell\u2019Omo, R., and Costagliola, C. (2020). Effectiveness and Safety of Topical Chlorhexidine and Vitamin E TPGS in the Treatment of Acanthamoeba Keratitis: A Survey on 29 Cases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113775"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1177\/00220345900690030901","article-title":"In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse","volume":"69","author":"Bernstein","year":"1990","journal-title":"J. Dent. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jcrs.2010.11.028","article-title":"In vitro efficacy of a povidone-iodine 0.4% and dexamethasone 0.1% suspension against ocular pathogens","volume":"37","author":"Pelletier","year":"2011","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/ICO.0b013e31815c5a3f","article-title":"Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers","volume":"27","author":"Pinna","year":"2008","journal-title":"Cornea"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/8\/1550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:32:41Z","timestamp":1760164361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/8\/1550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["microorganisms9081550"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms9081550","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}